| Financial Year |
March 31 2023 |
| Monetary Funds |
1,148,232,689.69 |
| Held-for-trading Financial Assets |
102,962,850.00 |
| Notes Receivable |
72,825,882.85 |
| Accounts Receivable |
942,755,532.22 |
| Advances to Suppliers |
319,973,600.05 |
| Other Receivables |
243,039,156.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
603,742,534.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,018,623.87 |
| Total Current Assets |
3,842,448,879.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,499,681,990.92 |
| Investment Properties |
39,117,148.39 |
| Fixed Assetes |
1,808,055,446.01 |
| Under-construction Projects |
166,020,198.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
211,152,857.94 |
| R&D expenses |
11,798,796.53 |
| Goodwill |
146,063,596.63 |
| Long-Term Deferred and Prepaid Expenses |
29,417,760.46 |
| Deferred Income Tax Assets |
100,279,598.26 |
| Other Non-Current Assets |
232,289,479.05 |
| Sub-Total of Non-Current Assets |
4,294,280,275.67 |
| Total Assets |
8,136,729,155.15 |
| Short-Term Loans |
1,573,190,160.49 |
| Trading Financial liabilities |
-- |
| Notes Payable |
536,737,088.38 |
| Accounts Payable |
748,561,953.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,875,014.15 |
| Taxes Payable |
49,620,811.01 |
| Interest Payable |
-- |
| Dividend Payable |
3,561,131.43 |
| Other payables |
227,388,170.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,473,578.47 |
| Other Current Liabilities |
1,340,694.75 |
| Sub-Total of Current Liabilities |
3,851,391,645.87 |
| Long-term Loans |
710,658,204.73 |
| Bonds Payable |
244,631,785.96 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,726,534.87 |
| Deferred Income Tax Liabilities |
2,462,512.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,053,035,667.18 |
| Total Liabilities |
4,904,427,313.05 |
| Paid-In Capital(Or Share Stock) |
1,405,152,059.00 |
| Capital Surplus |
1,058,711,997.70 |
| Surplus Reserve |
300,746,603.05 |
| LESS:Treasury Stock |
50,449,288.80 |
| Undistributed Profits |
248,542,791.69 |
| Minority Stockholder's Interest |
224,736,228.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,007,565,613.68 |
| Owner's Equity（Stockholder's Equity） |
3,232,301,842.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,136,729,155.15 |
